www.fdanews.com/articles/86589-sanofi-aventis-profits-rise-53-6-percent-on-exubera-licence-sale
SANOFI-AVENTIS PROFITS RISE 53.6 PERCENT ON EXUBERA LICENCE SALE
May 5, 2006
Pharmaceutical group Sanofi-Aventis has reported that first-quarter net profit had surged by 53.6 percent with a big injection from the sale of the patent for diabetes treatment Exubera to US group Pfizer.
TODAYonline (http://www.todayonline.com/articles/116674.asp)